Vials get left on counters
Experts increasingly expect retatrutide to emerge as a pivotal variable capable of reshaping the market, given that it has repeatedly delivered strong results in clinical studies over the past several years, provided issues such as side effects are improved
Plan your workouts around when you feel your best
Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial
Side effects tend to spike within the first week of each dose increase, then gradually subside
Ice after injection for 5 minutes